• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Insurance linked to black-white survival disparities in colorectal cancer

Bioengineer by Bioengineer
November 14, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Health insurance coverage differences account for nearly one-half of the black-white survival disparity in colorectal cancer patients, according to a new study. The study, published in Gastroenterology, reinforces the importance of equitable health insurance coverage to mitigate the black-white survival disparity in colorectal cancer.

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in both men and women in the United Sates. Overall CRC incidence and mortality rates are decreasing in the United States as a result of earlier detection and improved treatments. Nonetheless, CRC incidence and mortality rates continue to be higher in blacks than in whites.

For the new study, investigators led by Helmneh Sineshaw, M.D., MPH, at the American Cancer Society with collaborators from Dana-Farber Cancer Institute at Harvard Medical School, focused on the impact of access to care on black-white survival disparity. They looked at 199,098 CRC patients ages 18 to 64 in the National Cancer Database.

They found the absolute 5-year survival difference between black and white CRC patients in the entire cohort was 9.2% (57.3% vs 66.5%). That difference was cut almost in half, to 4.9%, after matching for insurance status. Tumor characteristics also played a large role. The survival difference dropped to 2.3% after tumor characteristics matching.

"These findings reinforce the importance of equitable health insurance coverage to mitigate the survival disparity between black versus white CRC patients in this age range, and underscore the need for further studies to elucidate reasons for racial differences in tumor characteristics," write the authors.

In October, an American Cancer Society study found that differences in insurance explained one-third of the black-white difference in women with early-stage breast cancer.

###

Article: Sineshaw HM, Ng K, Flanders WD, Brawley OW, Jemal A, Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer, Gastroenterology (2017), doi: 10.1053/j.gastro.2017.11.005.

URL upon publication: http://dx.doi.org/10.1053/j.gastro.2017.11.005

Media Contact

David Sampson
[email protected]
@ACSNews

http://www.cancer.org

http://dx.doi.org/10.1053/j.gastro.2017.11.005

Share12Tweet7Share2ShareShareShare1

Related Posts

PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T

November 9, 2025

Building Inclusive Retirement Home Policies: A Study

November 9, 2025

Desmopressin’s Role in Renal Biopsy Bleeding Outcomes

November 9, 2025

Impact of Perfluoroalkyl Substances on E. coli Phases

November 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    315 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    207 shares
    Share 83 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1303 shares
    Share 520 Tweet 325

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

PD-1 Inhibitors Enhance Outcomes After CD19 CAR-T

Building Inclusive Retirement Home Policies: A Study

Desmopressin’s Role in Renal Biopsy Bleeding Outcomes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.